Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	103	44	31	63	22	8
Market Cap Growth	57.21%	38.87%	-50.29%	186.24%	193.07%	-50.11%
Enterprise Value	61	-7	-24	-21	-92	-1
PE Ratio	-	-1.08	-0.36	-1.83	-0.97	-0.47
PB Ratio	1.39	0.52	0.37	0.39	0.12	0.80
P/FCF Ratio	-1.33	-1.10	-1.10	-2.18	-1.45	-0.54
P/OCF Ratio	-1.33	-1.10	-1.10	-2.18	-1.45	-0.54
EV/EBITDA Ratio	-0.22	0.18	0.28	0.57	3.99	0.06
EV/EBIT Ratio	-0.21	0.18	0.28	0.57	3.96	0.06
EV/FCF Ratio	-0.22	0.18	0.85	0.73	6.05	0.07
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.03
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.02	-0.01	-0.02
Debt / FCF Ratio	-0.01	-0.01	-0.03	-0.03	-0.01	-0.02
Quick Ratio	10.09	13.12	8.71	19.28	45.99	6.65
Current Ratio	11.30	14.41	9.19	20.07	46.57	7.54
Return on Equity (ROE)	-45.60%	-46.20%	-66.30%	-19.80%	-39.10%	-131.30%
Return on Assets (ROA)	-42.80%	-43.10%	-63.00%	-19.10%	-22.00%	-110.80%
Return on Capital (ROIC)	-56.93%	-51.31%	-104.12%	-22.38%	-9.68%	-163.97%
Earnings Yield	-38.33%	-92.58%	-280.45%	-54.69%	-103.49%	-212.88%
FCF Yield	-36.88%	-90.75%	-90.62%	-45.83%	-69.01%	-184.24%
Buyback Yield / Dilution	-109.92%	-72.34%	3.61%	-921.03%	-121.41%	-31.03%
Total Shareholder Return	-109.92%	-72.34%	3.61%	-921.03%	-121.41%	-31.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).